Challenge: expanding access to hepatitis B care and treatment.
Effective, low-cost antiviral medications can treat hepatitis B, cutting liver cancer risk in half. However, of the estimated 254 million people with hepatitis B, only 13% are diagnosed and a scant number receive treatment.
The World Health Organization (WHO) recently simplified treatment criteria, increasing eligibility for treatment by non-liver specialists. To improve the health of people with hepatitis B in low- and middle-income countries, the recently launched Center for Operational Research on Hepatitis B is seeking to develop pathways of simplified care and integrated service delivery.


Comments
Post a Comment